Agr Typing and Detection of Mupirocin Resistance in Multi-Drug Resistant Clinical Isolates of Staphylococcus aureus in Northern Iran

Document Type : Original Research

Authors
Department of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran
Abstract
Background: Mupirocin is a topical antibiotic inhibiting most Gram-positive cocci. Shortly after taking mupirocin, drug resistance emerges. This study aimed to determine mupirocin resistance in Staphylococcus aureus strains isolated from clinical specimens in Rasht.

Materials & Methods: In this study, a total of 85 clinical isolates of S. aureus were collected. Biofilm formation ability and antibacterial resistance patterns of isolates were investigated. Disc diffusion method and MIC determination were used to determine the susceptibility of strains to mupirocin antibiotic. Agr types, the presence of mupA, and mutation in ileS-1 were evaluated in mupirocin non-susceptible isolates by PCR and PCR sequencing, respectively.

Findings: Out of 85 tested strains, 57 (67%) isolates were recognized as biofilm producers, and all of which showed multidrug resistance phenotype. Agr type 1 was the most commonly detected type. Additionally, 12 mupirocin-resistant strains were identified in the disc diffusion and MIC tests. A total of four strains were mup-A positive and showed high-level resistance. In sequencing and mutation evaluation of the ileS-1 gene in eight low-level mupirocin-resistant strains, 12 types of silent mutation and one type of missense mutation were determined.

Conclusion: The study of mupirocin-resistant strains in this study showed the need to identify factors affecting the occurrence of resistance and to take control and prevention measures before mupirocin losses its efficacy.

Keywords

Subjects


1. Goudarzi M, Fazeli M, Eslami G, Pouriran R. Genetic Diversity Analysis of Mupirocin-Resistant Staphylococcus aureus Clinical Isolates in Tehran Hospitals, Iran. Microbial Drug Resistance. 2019 May 1;25(4):558-66.
2. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010;23:616–687.
3.Wertheim HF, Melles DC, Vos MC, Leeuwen W, Belkum A. The role of nasal carriage in Staphylococcus aureus infections. J Lancet Infect Dis. 2005; 5(12): 751-762.
4. Nakama T, Nureki O, Yokoyama S. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. J Biol Chem 2001;276:47387–47393.
5.Sandra Matthijs, Corinne Vander Wauven, Bertrand Cornu, Lumeng Ye, Pierre Cornelis، Christopher M. Thomas, Marc Ongena Antimicrobial properties of Pseudomonas strains producing the antibiotic mupirocin. Research in Microbiology.2014; 165: 695-704.
6. Chen S, Jin Y, Lin C, Hao Z, Duan J, Guo Y, Wang S, Hu L, Wang L, Yu F. Low prevalence of mupirocin resistance among Staphylococcus aureus clinical isolates from a Chinese tertiary hospital. Journal of medical microbiology. 2019 Feb 1;68(2):201-5.
7.Driscoll DG, Young CL, Ochsner UA. Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to mupA Polymorphism. Antimicrob Agents Chemother. 2007;51(6):2247-2248.
8.Seah C, Louie L, Simor A, Donald E,Roberto G. MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus. J Antimicrob Agents Chemotherapy. 2012; 56(4): 1916-1920.
9.Godbeer MS, Gold RM, Lawhon SD. Prevalence of mupirocin resistance in Staphylococcus pseudintermedius. J Clin Microbiol. 2014;52(4):1250-2.
10. Mahmoudi S, Mamishi S, Mohammadi M, Banar M, Ashtiani MT, Mahzari M, Bahador A, Pourakbari B. Phenotypic and genotypic determinants of mupirocin resistance among Staphylococcus aureus isolates recovered from clinical samples of children: an Iranian hospital-based study. Infection and drug resistance. 2019;12:137.
11. Javdan S, Narimani T, Abadi MS, Gholipour A. Agr typing of Staphylococcus aureus species isolated from clinical samples in training hospitals of Isfahan and Shahrekord. BMC research notes. 2019 Dec;12(1):1-6.
12. Bibalan MH, Shakeri F, Javid N, Ghaemi A, Ghaemi EA. Accessory gene regulator types of Staphylococcus aureus isolated in Gorgan, North of Iran. Journal of clinical and diagnostic research: JCDR. 2014 Apr;8(4):DC07.
13. Paniagua-Contreras G, Sáinz-Espuñes T, Monroy-Pérez E, Rodríguez-Moctezuma JR, Arenas-Aranda D, Negrete-Abascal E, et al. Virulence markers in Staphylococcus aureus strains isolated from hemodialysis catheters of Mexican patients. Adv Microbiol. 2012;2(04):476.
14.Cha JO, Yoo JI, Yoo JS, Chung HS, Park SH, Kim HS, Lee YS, Chung GT. Investigation of biofilm formation and its association with the molecular and clinical characteristics of methicillin-resistant Staphylococcus aureus. Osong public health and research perspectives. 2013 Oct 1;4(5):225-32.
Magiorakos AP, Srinivasan A, Carey RT, Carmeli Y, Falagas MT, Giske CT, Harbarth S, Hindler JT, Kahlmeter G, Olsson-Liljequist B, Paterson DT. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection. 2012 Mar 1;18(3):268-81.

16. Grinholc M, Nakonieczna J, Negri A, Rapacka-Zdonczyk A, Motyka A, Fila G, Kurlenda J, Leibner-Ciszak J, Otto M, Bielawski KP. The agr function and polymorphism: impact on Staphylococcus aureus susceptibility to photoinactivation. Journal of Photochemistry and Photobiology B: Biology. 2013, 5;129:100-7.
17. Mohajeri P, Gholamine B, Rezaei M, Khamisabadi Y. Frequency of Mupirocin resistant Staphylococcus aureus strains isolated from nasal carriers in hospital patients in Kermanshah. Jundishapur J Microbiol. 2012 1;5(4):560-3.
18.Orrett FA. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad. JPN J Infect Dis. 2008; 61:107-110.
19. Fujimura S, Tokue Y, Watanabe A, Isoleucyl-tRNA synthetase mutation in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains. Antimicrobial Agents and Chemotherapy.2003:3373-3374.
20. Antonio M, McFerran N, Pallen MJ. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother.2002; 46:438–442.

21.Yang JA, Park DW, Sohn JW, Yang IS, Kim KH, Kim MJ, Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance. J Korean Med Sci. 2006; 21: 827-32.
22. Hesami S, Hosseini SD, Amouzandeh-Nobaveh A, Eskandari S, Ghaznavi-Rad E. Phenotypic and Genotypic Determination of Mupirocin Resistance Among Methicillin Susceptibility and Resistance in Staphylococci Isolated from Nosocomial Infections. Journal of Mazandaran University of Medical Sciences. 2014 Mar 15;23(1):30-9.
23.Daskalaki M, Otero JR, Chaves F. Molecular characterization of resistance to mupirocin in methicillin-resistant Staphylococcus aureus isolates in a tertiary hospital in Spain. J. Antimicrob Chemother. 2009; 63:826-845.
24.Chaturvedi p, Singh AK, Shukla S, Agarwal L. Prevalence of mupirocin resistant Staphylococcus aureus isolates among patients admitted to a tertiary care hospital. North American Journal of Medical Sciences. 2014; 6(8): 403–407.
25. Saderi, H., Oulia, P. and Habibi, M. Detection of resistance to mupirocin in Staphylococcus aureus strains isolated from patients in four university hospitals of Tehran by polymerase chain reaction (pcr) method. Daneshvar Medicine, December 2008-January 2009, Volume 16 , Number 78; 29-36.
26. Hesami, S., Hosseini, S.D., Amouzandeh-Nobaveh, A., Eskandari, S. and Ghaznavi-Rad, E. Phenotypic and genotypic determination of mupirocin resistance among methicillin susceptibility and resistance in Staphylococci isolated from nosocomial infections. Journal of Mazandaran University of Medical Sciences. 2014; 23, 30-39.
27. Hadadi M., Heidari H., Ebrahim-Saraie H.S., Motamedifar M. Molecular characterization of vancomycin, mupirocin and antiseptic resistant staphylococcus aureus strains. Mediterr J Hematol Infect Dis 2018, 10(1): e2018053.